Detection of antibiotics resistance e-coli gens isolates from urinary tract infection

Yousra Kareem; Baydaa A. Hassan

doi:10.53730/ijhs.v6nS2.5160

Authors

Yousra Kareem
yousrakareemsabar@gmail.com
University of Kufa, Faculty of Science, Department of Biology, Iraq
Baydaa A. Hassan University of Kufa, Faculty of Science, Department of Biology, Iraq

Keywords:

esherichia coli, infection, resistance gens, urinary tract

Abstract

This study was completed in laboratories of Biology Department in Faculty of Science. It explains of antibiotics resistance Escherichia coli that isolated from urinary tract Infection patients in the province of Najaf. A total number of (225) samples were collected from patients with from hospitals and laboratories AL-Najaf Governorate, E.coli isolated from urinary tract Infection infection revealed that 80 E.coli isolates against 22 commonly used antibacterial agents by using the disk diffusion method. E. coli isolates has a great resistance to most commonly antibiotics used in treatment of urinary tract Infection, the highest rate of resistance is seen with, Ciprofloxacin, Levofloxacin 60 /80 ( 75 %) followed by Norfloxacine 57/80 (71.25 %) Trimethoprime-sulfamethaxazol 55/80 (68.75 %), The results showed that the( gyrA) gene was detected in E. coli isolates, from the 30 (100%) all isolates of E. coli were have (gyr A) gene. The results also showed that the (Sul1)gene was detected in E. coli isolates, from the 30 (100%) isolates of E. coli 24 (80%) were have (Sul1) gene, while the results showed four positive isolates of the Ant(2")-1a , from the 30 (100%) isolates of E. coli 4 (13.3%) were have ( Ant(2")-1a) gene.

Downloads

Download data is not yet available.

References

Carvalho, D.D.M.; Takeuchi, K.P.; Geraldine, R.M.; De Moura, C.J.; Torres, M.C.L. Production, solubility and antioxidant activity of curcumin nanosuspension. Food Sci. Technol. 2015, 35, 115–119. [CrossRef

Rahman , AE., Iqbal ,A., Hoque DE, et al. (2017) . Managing neonatal and early childhood syndromic sepsis in sub-district hospitals in resource poor settings: improvement in quality of care through introduction of a package of interventions in rural Bangladesh. PloS one. , 12:10.1371.

Zabawa , TP., Pucci ,MJ., Parr, TR., Jr. et al. (2016) . Treatment of gram-negative bacterial infections by potentiation of antibiotics. Curr Opin Microbiol ;33:7–12. 4. Zabawa , T.P.; Pucci, M.J.; Parr, T.R., Jr. et al. (2016) . Treatment of gram-negative bacterial infections by potentiation of antibiotics. Curr Opin Microbiol ;33:7–12.

Yang, J.L.; Wang, M.S. ; Cheng, A.C.; Pan, K.C. ; Li, C.F. and Deng, S.X. (2008). A simple and rapid method for extracting bacterial DNA from intestinal microflora for ERIC-PCR detection. World J. Gastroenterol., 14: 2872-2876.

Minh, C. ;Phuc, N.; Paul-Louis, W.; Mathilde, B.; Antoine, A.; Roland, L. and Annie, C. (2009). Escherichia coli as Reservoir for Macrolide Resistance Genes. Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 15, No. 10,

Aggen, J.B.; Armstrong, E.S. and Goldblum, A.A. (2010). Synthesis and spectrum of the neoglycoside ACHN-490. Antimicrob Agents Chemother;54:4636–42.

Cattoir, V.; Poirel, L.; Rotimi, V.; Soussy, C.J. and Nordmann, P.(2007). Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates.J Antimicrob Chemother.;60(2):394–397.

Johnning, A.; Kristiansson, E.; Fick, J.; Weijdegård, B. and Larsson, D.G.J. (2015) .Resistance Mutations in gyrA and parC are Common in Escherichia Communities of both Fluoroquinolone-Polluted and Uncontaminated Aquatic Environments. Front. Microbiol. 6:1355.

Hopkins, K L, Davies, R. H, and Threlfall, E J. (2005). Mechanisms of quinolone resistance in Escherichia coli and Salmonella: recent developments. Int. J. Antimicrob Agents 25, 358—373.

Yoshida, H., Bogakl, M., Nakamura, Yamanaka, L M., and Nakamura, S. (1991).

Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli. Antimicrob. Avnts Chemother- 35, 1647—1650.

Suzuki S, Hoa VT. (2012). Distribution of quinolones, sulfonamides tetracyclines in aquatic environment and antibiotic resistance in indochina. Front Microbiol., 367.

Wu S, Dalsgaard A, Hammerum AM, Porsbo Ll. Jensen LB. (2010) .Prevalence and characterization of plasmids carrying sulfonamide resistance genes among Escherichia coli from pigs, pig carcasses and human. Acta Vet Scand.;52:47.

Trobos M, Jakobsen L Olsen KE, Frimodt-Moller N, Hammerum AM, Pedersen K, et al. (2008) . Prevalence of sulphonamide resistance and class 1 integron genes in Escherichia coli isolates obtained from broilers, broiler meat, healthy humans and urinary infections in Denmark Int]Antimicrob Agents. 32(4) B67-9.

Chuanchuen R, , Koowatananukul C, Khemtong S. Characterization of class 1 integrons with unusual 3' conserved region from Salmonella enterica isolates. Southeast Asian J Ti•op Med Public Health.. 2008 39(3. ) ;419_24.

Davis MA, Baker KN, Orfe LH et al Discovery of a gene conferring multiple-aminoglycoside resistance in Escherichia coli. Antimicrob Agents Chemother 2010;54:2666—9.

Garneau-Tsodikova S, Labby KJ. Mechanisms of resistance to aminoglycoside antibiotics: overview and perspectives. MedChemComm.

Wachino Jl. Arakawa Y. Exogenously acquired 16S rRNA methyltransferases found in aminoglycoside-resistant pathogenic Gram negative bacteria: an update. Drug Resist Updat

Livermore D, Mushtaq S, Warner M et al. (2011). Activity Of aminoglycosides, including ACHN-490, against carbapenemresistant Enterobacteriaceae isolates. J Antimicrob Chemother.

Leclercq R. (2002) . Me&nisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications_ Clin Infect Dis.

O'Hara K, Kanda T, Ohmiya K, Ebisu T, Kono M.(1989). Purification and charactenzation of macrolide 2 '-phosphotransferase from a strain of Escherichia coli that is highly resistant to erythromycin. Antimicrob Agents Chemother.

Ojo KK, Ulep C, Van Kirk N, Luis H, Bernardo M, Leitao J, et al. (2004) . meAA) gene predominates arming seven macrolide resistance genes identified in gram-negative strains representing 13 genera, isolated from healthy Portuguese children. Antimicrob Agents Chemother,48 3451-6.

Leclercq R. (2002). Me&nisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications_ Clin Infect Dis.

Thakuria B ., and Lahon K.(2013) . The Beta Lactam Antibiotics as an Empirical Therapy in a Developing Country: An Update on Their Current Status and Recommendations to Counter the Resistance against Them. J Clin Diagn Res. Jun;7(6):1207-14

Eckburg PB, Lister T, Walpole S, Keutzer T, Utley L, Tomayko J, Kopp E, Farinola N, Coleman S. Safety . (2019) . Tolerability, Pharmacokinetics, and Drug Interaction Potential of SPR741, an Intravenous Potentiator, after Single and Multiple Ascending Doses and When Combined with β-Lactam Antibiotics in Healthy Subjects. Antimicrob Agents Chemother. ;63(9) .

Bush, K. (2010). Alarming β-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae. Curr. Opin. Microbiol. 13, 558–564.

Bush, K., and Fisher, J. F. (2011). Epidemiological expansion, structural studies, and clinical challenges of new β-lactamases from Gram- negative bacteria. Annu. Rev. Microbiol. 65, 455–478.